Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Histiocytic Disorders and Treatments, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Asthma and respiratory diseases, and Rheumatoid Arthritis Research and Therapies.
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms
<i>BRAF</i> V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
Long-term outcomes among adults with Langerhans cell histiocytosis
Neurological Manifestations of Histiocytic Disorders
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on <i>KRAS</i> and <i>MEK</i> Alteration Status
Sustained, complete response to pexidartinib in a patient with <scp><i>CSF1R</i></scp>‐mutated Erdheim–Chester disease
Classical and <scp>non‐classical</scp> phenotypes of <scp>Erdheim–Chester</scp> disease: Correlating clinical, radiographic and genotypic findings
Ophthalmologic Involvement in Adults with Histiocytic Disorders
Efficacy of MEK Inhibitors in Erdheim Chester Disease
Sirolimus as frontline therapy for <i>PTEN</i>-mutated histiocytic sarcoma
Immune signatures underlying post-acute COVID-19 lung sequelae
Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis
Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival
Methotrexate and rheumatoid arthritis associated interstitial lung disease
Efficacy of BRAF-Inhibitor Therapy in <i>BRAF</i> <i>V600E</i>-Mutated Adult Langerhans Cell Histiocytosis
A National Survey of Burnout and Depression Among Fellows Training in Pulmonary and Critical Care Medicine
Low-dose vemurafenib monotherapy in <i>BRAF<sup>V600E</sup></i>-mutated Erdheim-Chester disease
PD-1 <sup>hi</sup> CD8 <sup>+</sup> resident memory T cells balance immunity and fibrotic sequelae
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages